YBX1 and neoplasm: In the present study, we searched for possible candidate downstream mRNAs of circRAD23B by RNA-seq and found that YBX1 presented the largest differential fold change after knockdown of circRAD23B, which is a reported tumour promoter and chemoresistance inducer in OC [39–41].